UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032934
Receipt number R000037545
Scientific Title Association of the Serum Triglyceride/high-density Lipoprotein Cholesterol Ratio with Low-density Lipoprotein Heterogeneity: A Pilot Cross-sectional and Longitudinal Study
Date of disclosure of the study information 2018/06/11
Last modified on 2018/12/10 06:50:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Association of the Serum Triglyceride/high-density Lipoprotein Cholesterol Ratio with Low-density Lipoprotein Heterogeneity: A Pilot Cross-sectional and Longitudinal Study

Acronym

TG/HDL ratio and LDL heterogeneity

Scientific Title

Association of the Serum Triglyceride/high-density Lipoprotein Cholesterol Ratio with Low-density Lipoprotein Heterogeneity: A Pilot Cross-sectional and Longitudinal Study

Scientific Title:Acronym

TG/HDL ratio and LDL heterogeneity

Region

Japan


Condition

Condition

patients with one additional risk factor for atherosclerosis.

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study was designed as a hospital-based cross-sectional and longitudinal study to investigate the relationships between the serum TG/HDL-C ratio and LDL-heterogeneity, as assessed by polyacrylamide-gel electrophoresis (PAGE), in patients with one or more risk factors for ACVD. Furthermore, we examined the relationship between the changes in the TG/HDL-C ratio and the change in the LDL particle size in cases in which additional measurements could also be conducted 1 year later.

Basic objectives2

Others

Basic objectives -Others

A receiver-operating characteristic analysis was performed to determine the cutoff value of the TG/HDL-C ratio for LDL-Rm values>0.40.

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

1)the relationships between the serum TG/HDL-C ratio and LDL-heterogeneity, as assessed by polyacrylamide-gel electrophoresis (PAGE)in patients with one or more risk factors for ACVD.
2)Furthermore, we examined the relationship between the changes in the TG/HDL-C ratio and the change in the LDL particle size in cases in which additional measurements could also be conducted 1 year later.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

The criterion for patient registration in the cross sectional study was the presence of one or more risk factors for atherosclerosis.

Key exclusion criteria

Patients were not enrolled if they met any of the following exclusion criteria: presence of hepatic dysfunction (serum alanine aminotransferase and aspartate aminotransferase levels 2 times the upper limit of normal),known malignant disease, diagnosis of acute coronary syndrome within 3 months prior to the study, and/or serum TG 400 mg/dL.

Target sample size

700


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shigemasa Tani

Organization

Nihon University Hospital

Division name

Health Plannning Center

Zip code


Address

1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo , Japan

TEL

03-3293-1711

Email

tanishigem@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shigemasa Tani

Organization

Nihon University Hospital

Division name

Health Planning Center

Zip code


Address

1-6 Kanda-Surugadai, Chiyoda-ku, Tokyo , Japan

TEL

03-3293-1711

Homepage URL


Email

tanishigem@yahoo.co.jp


Sponsor or person

Institute

Department of Health Planning Center, Nihon-University Hospital

Institute

Department

Personal name



Funding Source

Organization

Department of Health Planning Center, Nihon-University Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 06 Month 11 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2009 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2018 Year 07 Month 30 Day


Other

Other related information

This study was designed as a hospital-based cross-sectional and longitudinal study to investigate the relationships between the serum TG/HDL-C ratio and LDL-heterogeneity, as assessed by polyacrylamide-gel electrophoresis (PAGE), in patients with one or more risk factors for ACVD. Furthermore, we examined the relationship between the changes in the TG/HDL-C ratio and the change in the LDL particle size in cases in which additional measurements could also be conducted 1 year later.


Management information

Registered date

2018 Year 06 Month 09 Day

Last modified on

2018 Year 12 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037545


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name